Walter J Lunsmann

Title: Walter J Lunsmann: Innovator in Sleep Apnea Treatment

Introduction

Walter J Lunsmann is a notable inventor based in Harvard, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of sleep apnea. His innovative approach combines existing medications to enhance therapeutic outcomes for patients suffering from this condition.

Latest Patents

Walter J Lunsmann holds a patent for "Methods for treating sleep apnea with combinations of atomoxetine and (R)-oxybutynin." This invention relates to pharmaceutical compositions that include (R)-oxybutynin and a norepinephrine reuptake inhibitor (NRI). The methods described in the patent focus on administering these compounds to effectively treat sleep apnea. In some embodiments, the NRI utilized is atomoxetine. This patent highlights Lunsmann's commitment to advancing medical treatments and improving patient care.

Career Highlights

Walter J Lunsmann is associated with Apnimed, Inc., a company based in Delaware. His work at Apnimed has allowed him to collaborate with other professionals in the field, contributing to the development of innovative solutions for sleep disorders. His dedication to research and development has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Walter has worked alongside notable colleagues such as Lawrence G Miller and Barry Wohl. These collaborations have fostered an environment of innovation and have led to advancements in the treatment of sleep apnea.

Conclusion

Walter J Lunsmann's contributions to the field of sleep apnea treatment through his patent and work at Apnimed, Inc. demonstrate his commitment to improving healthcare solutions. His innovative methods have the potential to significantly impact the lives of those affected by sleep disorders.